Lightcast Discovery
Lightcast | Profiling Function, Cell by Cell
Cambridge, United Kingdom · $97.1M raised
- Headquarters
- Cambridge
- Employees
- 11–50
- Business Model
- B2B
- Website
- lightcast.bio
- Total Funding
- $97.1M
- Last Round
- $49.0M Series BAug 2023
- Rounds
- 3
About
Biotech company developing a droplet-based microfluidics platform for single-cell functional analysis at scale.
Summary
Lightcast Discovery is a Biotech company based in Cambridge, United Kingdom. It has raised $97.1M in total across 3 rounds, most recently a $49.0M Series B round in Aug 2023. Investors include ARCH Venture Partners, M Ventures and Northpond Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...